Pancreatic Cancer Research

ResearcherMayo ClinicNo recent work listed

Amylou Constance Dueck

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9912-1085; OpenAlex author ID A5090009905. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 3

  1. Patient-reported Adverse Events During Neoadjuvant Therapy in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501). First author DOI 10.1097/sla.0000000000005958↗
  2. Evaluation of Minimal Important Difference and Responder Definition in the EORTC QLQ-PAN26 Module for Assessing Health-Related Quality of Life in Patients with… Last author DOI 10.1245/s10434-021-09816-z↗
  3. Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy: A Systematic Literat… Co-author DOI 10.1097/mpa.0000000000001507↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew Eugene Hendifar · 2 shared papers, 2020–2021 · strength 0.22
  2. Do‐Youn Oh · 2 shared papers, 2020–2021 · strength 0.22
  3. Marc F Botteman · 2 shared papers, 2020–2021 · strength 0.22
  4. Chung‐Pin Li · 2 shared papers, 2020–2021 · strength 0.22
  5. Michele Reni · 2 shared papers, 2020–2021 · strength 0.22
  6. Margaret A. Tempero · 2 shared papers, 2020–2021 · strength 0.22
  7. Hanno B. Riess · 2 shared papers, 2020–2021 · strength 0.22
  8. Teresa Mercade Macarulla · 2 shared papers, 2020–2021 · strength 0.22
  9. Matthew H. G. Katz · 1 shared paper, 2023 · strength 0.19
  10. Joleen Marie Hubbard · 1 shared paper, 2023 · strength 0.19
  11. Eileen Mary O'Reilly · 1 shared paper, 2023 · strength 0.19
  12. Joseph M. Herman · 1 shared paper, 2023 · strength 0.19
  13. Rebecca Anne Snyder · 1 shared paper, 2023 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.